| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/09/1996 | US5534660 Ph genes and their uses |
| 07/09/1996 | US5534631 Cellular factor ILF |
| 07/09/1996 | US5534619 Synthetic polypeptides having cationically charged and uncharged segments |
| 07/09/1996 | US5534617 Human growth hormone variants having greater affinity for human growth hormone receptor at site 1 |
| 07/09/1996 | US5534615 Cardiac hypertrophy factor and uses therefor |
| 07/09/1996 | US5534498 Trypsin inhibitors |
| 07/09/1996 | US5534495 Administering linear oligopeptide |
| 07/09/1996 | US5534494 Polypeptide compounds having growth hormone releasing activity |
| 07/09/1996 | US5534488 Combining zinc with insulin and proteins |
| 07/09/1996 | US5534439 Isolated DNA of human papillomavirus type 55 (HPV55) |
| 07/09/1996 | US5534438 Process for isolating genes and the gene causative of Huntington's disease and differential 3' polyadenylation in the gene |
| 07/09/1996 | US5534419 Method of producing foreign gene products |
| 07/09/1996 | US5534418 Controlled expression of recombinant proteins |
| 07/09/1996 | US5534414 Process for preparing conjugates consisting of a specific binding partner and a carbohydrate-containing protein |
| 07/09/1996 | US5534413 Adherent and invasive mycoplasma |
| 07/09/1996 | US5534410 TATA-binding protein associated factors drug screens |
| 07/09/1996 | US5534409 Cytokine regulated transcription factor |
| 07/09/1996 | US5534405 Antibodies, diagnostic systems and methods for assaying HBxAg |
| 07/09/1996 | US5534257 Genetic engineering; insertion of foreign peptide epitope; vaccines |
| 07/09/1996 | US5534255 Immunoassay |
| 07/09/1996 | US5534251 Stabilized il-1α medicinal composition |
| 07/09/1996 | US5534223 Immunoenzymological assay for proteins using alkaline phosphatase joined to polypeptides and interacting with antigens or antibodies |
| 07/09/1996 | CA1338453C Purified protein having angiogenic activity and methods of preparation |
| 07/09/1996 | CA1338441C Expression of immunologically active proteins of human .beta.-lympho tropic virus |
| 07/09/1996 | CA1338440C Process for the isolation and characterisation of a gene enzyme system for inactivation of the herbicide phenmedipham |
| 07/04/1996 | WO1996020403A1 Assay, receptor proteins and ligands |
| 07/04/1996 | WO1996020284A1 Hydroxyproline-rich proteins and pharmaceutical and cosmetic formulations containing them |
| 07/04/1996 | WO1996020278A2 Genetically engineered human-derived kunitz domains that inhibit human neutrophil elastase |
| 07/04/1996 | WO1996020277A2 Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen |
| 07/04/1996 | WO1996020219A2 Murine monoclonal anti-idiotype antibody 3h1 |
| 07/04/1996 | WO1996020218A1 Antigen, antibodies and diagnostic assay for alzheimer's disease |
| 07/04/1996 | WO1996020216A1 Fibronectin adhesion inhibitors |
| 07/04/1996 | WO1996020215A2 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases |
| 07/04/1996 | WO1996020214A1 Tcf mutant |
| 07/04/1996 | WO1996020213A1 Recombinant antigen for diagnosing rheumatoid arthritis |
| 07/04/1996 | WO1996020212A2 Peptide nucleic acid incorporating a chiral backbone |
| 07/04/1996 | WO1996020211A1 Phosphotyrosine assay and peptides for use therein |
| 07/04/1996 | WO1996020207A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF |
| 07/04/1996 | WO1996020206A1 Secreted human fas antigen |
| 07/04/1996 | WO1996020042A1 ADSORBENT FOR ENDOTOXIN, TUMOR NECROSIS FACTOR-α OR INTERLEUKINS, METHOD FOR REMOVAL VIA ADSORPTION, AND ADSORBER |
| 07/04/1996 | WO1996020006A1 Vaccine against aids comprising a peptide sequence of hiv |
| 07/04/1996 | WO1996020005A1 Protracted glp-1 compositions |
| 07/04/1996 | WO1996020003A1 Methods for treatment or diagnosis of diseases or disorders associated with an apb domain |
| 07/04/1996 | WO1996020002A1 Immobilization of peptides to hyaluronate |
| 07/04/1996 | WO1996019999A1 Thrombolytic enzyme and method of obtaining same |
| 07/04/1996 | WO1996011664A3 NSK2 a muscle receptor tyrosine kinase |
| 07/04/1996 | DE4436664A1 Cells that stably express specific adeno-associated virus Rep proteins |
| 07/04/1996 | CA2228723A1 Assay, receptor proteins and ligands |
| 07/04/1996 | CA2211038A1 Secreted human fas antigen |
| 07/04/1996 | CA2208706A1 Mutants of the rb and p53 genes and uses thereof |
| 07/04/1996 | CA2208329A1 Antigen, antibodies and diagnostic assay for alzheimer's disease |
| 07/04/1996 | CA2208319A1 Assay, receptor proteins and ligands |
| 07/04/1996 | CA2208318A1 Phosphotyrosine assay and peptides for use therein |
| 07/04/1996 | CA2208233A1 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases |
| 07/04/1996 | CA2208072A1 Recombinant antigen for diagnosing rheumatoid arthritis |
| 07/04/1996 | CA2207820A1 Genetically engineered human-derived kunitz domains that inhibit human neutrophil elastase |
| 07/04/1996 | CA2204793A1 Fibronectin adhesion inhibitors |
| 07/03/1996 | EP0719864A2 Recombinant live avian vaccin, using an avian herpes virus as vector |
| 07/03/1996 | EP0719863A1 Hepatitis B surface antigen formed by recombinant DNA techniques, vaccines, diagnostics, cell lines and methods of forming same |
| 07/03/1996 | EP0719862A2 A regulatory factor for expression of nitrilase gene and a gene thereof |
| 07/03/1996 | EP0719861A1 Nucleic sequences from the genome of Salmonella Typhi, and uses thereof particularly for the in vitro diagnosis of the presence of salmonella bacteria in foodstuffs |
| 07/03/1996 | EP0719860A1 Compositions and method for treating or preventing infections in animals |
| 07/03/1996 | EP0719858A2 Myeloma cell line expressing recombinant human thyroid stimulating hormone receptor |
| 07/03/1996 | EP0719792A2 Somatotropin variants |
| 07/03/1996 | EP0719560A1 Antibordetella acellular vaccine |
| 07/03/1996 | EP0719343A1 Adeno-associated viral (aav) liposomes and methods related thereto |
| 07/03/1996 | EP0719341A1 Regulation of senescence |
| 07/03/1996 | EP0719339A1 Subtilisin bpn' variants with decreased adsorption and increased hydrolysis |
| 07/03/1996 | EP0719337A1 PURIFIED pH NEUTRAL RHIZOCTONIA LACCASES AND NUCLEIC ACIDS ENCODING SAME |
| 07/03/1996 | EP0719336A1 Modified plant viruses as vectors of heterologous peptides |
| 07/03/1996 | EP0719335A1 Hybrid toxin |
| 07/03/1996 | EP0719334A1 Pharmaceutical compositions containing ecotin and homologs thereof |
| 07/03/1996 | EP0719333A1 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
| 07/03/1996 | EP0719332A1 Monocyte macrophage line recombinant cells for gene therapy |
| 07/03/1996 | EP0719331A1 Eotaxin = eosinophil chemotactic cytokine |
| 07/03/1996 | EP0719330A1 Protocadherin proteins and their uses |
| 07/03/1996 | EP0719329A1 Human receptor h4-1bb |
| 07/03/1996 | EP0719328A1 Grb3-3 gene, variants and uses thereof |
| 07/03/1996 | EP0719284A1 Improvements in or relating to haemoglobin |
| 07/03/1996 | EP0719283A1 Factor for fibroblast colony forming unit |
| 07/03/1996 | EP0719282A1 Aids prophylactics |
| 07/03/1996 | EP0719281A1 Multiple branch peptide constructions for use against hiv |
| 07/03/1996 | EP0719155A1 $i(CAMPYLOBACTER JEJUNI) ANTIGENS, AND METHODS FOR THEIR PRODUCTION AND USE |
| 07/03/1996 | EP0719150A1 Cellular vaccine and methods of use for the treatment of solid tumor malignancies |
| 07/03/1996 | EP0719147A1 Gene therapy for solid tumors, papillomas and warts |
| 07/03/1996 | EP0502976B1 Production of recombinant polypeptides by bovine species and transgenic methods |
| 07/03/1996 | EP0441955B1 Production of biologically active insulin-like growth factor i from high expression host cell systems |
| 07/03/1996 | EP0417160B1 Method for hla dp typing |
| 07/03/1996 | EP0249613B1 Interleukin-4 protein having bcgf and tcgf activity on human cells (human interleukin-4) |
| 07/03/1996 | CN1125982A Methods of typing hepatitis C virus and reagents for use therein |
| 07/02/1996 | US5532366 Enzyme inhibitors |
| 07/02/1996 | US5532352 Chemically modifying hemoglobin for use in a blood substitute |
| 07/02/1996 | US5532351 Nucleic acid sequences encoding OMGP |
| 07/02/1996 | US5532348 E6 associated protein and methods of use thereof |
| 07/02/1996 | US5532347 DNA encoding α melanocyte stimulating hormone receptor |
| 07/02/1996 | US5532343 Purification and characterization of a glioma-derived growth factor having vascular endothelial cell growth promoting activity |
| 07/02/1996 | US5532341 Polypeptides for stimulating growth of bone marrow cells |
| 07/02/1996 | US5532340 Tumor suppressor protein PRB2, related gene products, and DNA encoding therefor |
| 07/02/1996 | US5532339 Fusion protein between human macif and a heterologous pi anchor domain |
| 07/02/1996 | US5532337 Proteins comprising calmodulin- and actin-binding human caldesmon polypeptide fragments |